HK$ 9.46
Key Takeaways
Risk factor
Good trading liquidity
Profitability factor
Very strong margins and returns
About
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, the Americas, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. It provides NBP soft capsules and injections...
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of fair value
Target Price
The average target price of 1093.HK is 12 and suggests 24% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
